Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Amination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107501266A details a novel Pd-catalyzed asymmetric allylic amination route for high-purity nucleoside intermediates, offering significant supply chain and cost advantages.
Novel low-cost route for Itopride HCl using N,N-dimethylethanolamine. Reduces cost by 30% and avoids high-pressure hydrogenation for scalable API manufacturing.
Patent CN111732536A reveals a catalyst-free, solvent-free thermal amination route for aminopyridines, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN111285775B reveals a high-efficiency iridium catalytic system for chiral amine synthesis, offering significant cost reduction and scalability for agrochemical intermediates.
Patent CN110551035A details high-efficiency iridium catalysis for chiral amines. Offers significant cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN101580473B reveals a mild 3-step synthesis for N-methyl p-nitroaniline. Achieve >98% purity and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN113548971B details a novel spermidine synthesis route offering significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN104262249A reveals solvent-free hydroamination for quinolones. Reduces waste and improves supply chain reliability for pharmaceutical manufacturers.
Novel two-step route for Orforglipron intermediate. High purity, scalable process reduces cost and supply chain risks for pharmaceutical manufacturing.
Patent CN108129357B details a novel one-pot method for producing high-purity anamorelin intermediates, offering significant safety and cost advantages for pharmaceutical supply chains.
Novel metal salt catalyzed amination method for quinoline derivatives. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel synthetic route for EPZ-6438 offers high yield and mild conditions. Ideal for reliable pharmaceutical intermediates supplier seeking cost reduction.
Patent CN109280011B reveals a high-yield synthesis for 2-bromopyrene. Discover cost-effective manufacturing and supply chain advantages for OLED intermediates.
Novel copper-catalyzed hydroamination method offers high atom economy and mild conditions for scalable pharmaceutical intermediate production.
Novel C-H amination method for gamma/delta-lactams offers high selectivity and cost-effective routes for complex API intermediates.
Patent CN106699628A reveals efficient levulinic acid conversion. Lower temperature, high yield pyrrolidone synthesis for reliable supply chain.
Novel patent CN119528902A offers high-yield KRAS G12D intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN111170918A details a cost-effective iridium-catalyzed C-H amination route for lactams, offering significant supply chain stability and reduced manufacturing costs for pharma intermediates.
Novel four-step synthesis of PARP1 inhibitor intermediate via nitration and oxidative deamination. Offers high purity and scalable route for pharmaceutical manufacturing.
Patent CN114853797B reveals a mild selenium-catalyzed method for alpha-amino boron compounds, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.